CBD giant CV Sciences reports $9 million loss in first quarter

CV Sciences, a CBD specialist based in Las Vegas, reported revenue of $14.9 million for its first quarter ended March 31, up 85% from the same period a year ago.

Net loss for the quarter was $9.4 million, compared with net income of $600,000 the prior year as the company expanded retail operations and recorded higher payroll and compensation expenses.

CV Sciences trades on over-the-counter markets under the ticker symbol CVSI.

To read more about CV Sciences’ latest earnings report, click here.